Thomas P. Loughran
- Immunology top 0.2%
- Genetics top 0.1%
- Pathology and Forensic Medicine top 0.2%
- Molecular Biology top 2%
- Oncology top 1%
- Co-authors
- Thierry LamyGordon StarkebaumPearlie K. Epling‐BurnetteLubomir SokolDavid J. FeithRavi KothapalliRéka AlbertJin Hong Liu
- Topics
- Chronic Lymphocytic Leukemia Research (99 papers)Lymphoma Diagnosis and Treatment (78 papers)Immune Cell Function and Interaction (61 papers)
- Cited by
- GeneticsImmunologyHematology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesFranceIndia
In The Last Decade
Thomas P. Loughran
243 papers receiving 10.1k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Immunology 4.5k
- Genetics 3.4k
- Pathology and Forensic Medicine 3.2k
- Molecular Biology 3.0k
- Oncology 2.3k
Countries citing papers authored by Thomas P. Loughran
This map shows the geographic impact of Thomas P. Loughran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Loughran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Loughran more than expected).
Fields of papers citing papers by Thomas P. Loughran
This network shows the impact of papers produced by Thomas P. Loughran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Loughran. The network helps show where Thomas P. Loughran may publish in the future.
Co-authorship network of co-authors of Thomas P. Loughran
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Loughran. A scholar is included among the top collaborators of Thomas P. Loughran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Loughran. Thomas P. Loughran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 12 | |
| 7 | 37 | |
| 8 | 4 | |
| 9 | 33 | |
| 10 | 16 | |
| 11 | 23 | |
| 12 | 32 | |
| 13 | 15 | |
| 14 | 23 | |
| 15 | 188 | |
| 16 | 58 | |
| 17 | 86 | |
| 18 | 50 | |
| 19 | 26 | |
| 20 | Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expressionbreakdown → | 505 |
About Thomas P. Loughran
Thomas P. Loughran is a scholar working on Genetics, Immunology and Hematology, having authored 251 papers that have together received 10.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (99 papers), Lymphoma Diagnosis and Treatment (78 papers) and Immune Cell Function and Interaction (61 papers). The work is most often cited by research in Genetics (3.4k citations), Immunology (4.5k citations) and Hematology (2.2k citations). Thomas P. Loughran has collaborated with scholars based in United States, France and India. Frequent co-authors include Thierry Lamy, Gordon Starkebaum, Pearlie K. Epling‐Burnette, Lubomir Sokol, David J. Feith, Ravi Kothapalli, Réka Albert, Jin Hong Liu, Mark Kester and Xin Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.